Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Prostate Cancer and Prostatic Diseases|June 8, 2018
Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysisPui San Tan, Pedro Aguiar, Benjamin Haaland, et al.
Southern Medical Journal|September 29, 2006
Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care settingSantiago Garcia, Mariana Canoniero, Gilberto Lopes, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 4, 2020
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care SystemPedro Aguiar, Felipe Roitberg, Gilberto Lopes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2014
Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutationsBenjamin Haaland, Pui San Tan, Gilberto de Castro, et al.
Oncotargets and Therapy|August 9, 2020
Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in ContextSneha Gullapalli, Jordi Remon, Lizza E L Hendriks, et al.
JCO Global Oncology|September 5, 2024
ASCO Global Guidelines: Methods and OpportunitiesZeba Aziz, Sarah Temin, Sarah Bachmann, et al.
JCO Global Oncology|June 9, 2020
Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of ImmunotherapyLuis E Raez, Andrés F Cardona, Oscar Arrieta, et al.
JCO Oncology Practice|May 11, 2022
Challenges in Genetic Testing and Treatment Outcomes Among Hispanics With Lung CancerLuis E Raez, Andrés F Cardona, Gilberto Lopes, et al.
The Oncologist|November 11, 2018
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging IssueLuis E Aguirre, Maria E Guzman, Gilberto Lopes, et al.
Journal of Global Oncology|August 8, 2018
The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving MedicinesPat Garcia-Gonzalez, Gilberto Lopes, Erin Schwartz, et al.
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Prostate Cancer and Prostatic Diseases|June 8, 2018
Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysisPui San Tan, Pedro Aguiar, Benjamin Haaland, et al.
Southern Medical Journal|September 29, 2006
Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care settingSantiago Garcia, Mariana Canoniero, Gilberto Lopes, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 4, 2020
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care SystemPedro Aguiar, Felipe Roitberg, Gilberto Lopes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2014
Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutationsBenjamin Haaland, Pui San Tan, Gilberto de Castro, et al.
Oncotargets and Therapy|August 9, 2020
Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in ContextSneha Gullapalli, Jordi Remon, Lizza E L Hendriks, et al.
JCO Global Oncology|September 5, 2024
ASCO Global Guidelines: Methods and OpportunitiesZeba Aziz, Sarah Temin, Sarah Bachmann, et al.
JCO Global Oncology|June 9, 2020
Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of ImmunotherapyLuis E Raez, Andrés F Cardona, Oscar Arrieta, et al.
JCO Oncology Practice|May 11, 2022
Challenges in Genetic Testing and Treatment Outcomes Among Hispanics With Lung CancerLuis E Raez, Andrés F Cardona, Gilberto Lopes, et al.
The Oncologist|November 11, 2018
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging IssueLuis E Aguirre, Maria E Guzman, Gilberto Lopes, et al.
Journal of Global Oncology|August 8, 2018
The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving MedicinesPat Garcia-Gonzalez, Gilberto Lopes, Erin Schwartz, et al.
Pageof 18